Skip to content

NOVOX ANDRO L.10 cm d.2 cm 1pc.

by MOSS S.p.A. 2 variants

Ref NMA-L10D02-1-L2

Expiring European Union

CE MDR

Valid until

6 Oct 2027

CE MDR certificate

FDA recalls

Not applicable

No FDA record for this device

Documents

1 certificate

Certifier Eurofins Product Testing Italy S.r.l.

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source EUDAMED, synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDR Number805452935NANLN Basic UDI-DI 08054529351824UDI-DIDate21 Jan 2026RegisteredStatusActive

Certificates

1 certificate · EUDAMED

EUDAMED certificates (1)
  • EPT 0477.MDR.22/4952 Expiring Expires in 340 days

    Quality management system EU MDR

    Certifier
    Eurofins Product Testing Italy S.r.l. 0477
    Issued
    7 Oct 2022
    Expires
    6 Oct 2027

Coverage

1 jurisdiction

SwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

European Union — CE/MDR Expiring

Specification

EUDAMED

Device Name
Novox Andro
Model / Reference
NMA-L10D02-1-L2
Primary DI / UDI-DI
08054529351824
Basic UDI-DI
805452935NANLN
EMDN Code
M040413 Interactive dressings
Device Class
Class IIb
EU market of registration
Croatia

Manufacturer details

EUDAMED SRN
IT-MF-000010071

Other devices from MOSS S.p.A.

See all devices from MOSS S.p.A. →

Properties

Other properties (13)

  • Sterile: No
  • Implantable: No
  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • CMR Substance: No
  • Human-derived: No
  • Human Tissues: No
  • Animal Tissues: No
  • Endocrine Disruptor: No
  • Administering Medicine: No
  • Measuring Function: No
  • Incorporates Medicinal Product: No